Stock Research for SPHS


Featured Broker: Ally Invest

Get the due diligence for another stock.


SPHS Stock Chart & Research Data

The SPHS chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the SPHS chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


SPHS Due diligence Resources & Stock Charts

The SPHS stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View SPHS Detailed Price Forecast - CNN Money CNN View SPHS Detailed Summary - Google Finance
Yahoo View SPHS Detailed Summary - Yahoo! Finance Zacks View SPHS Stock Research & Analysis -

Stock Analysis

TradeIdeas View SPHS Trends & Analysis - Trade-Ideas Barrons View SPHS Major Holders - Barrons
NASDAQ View SPHS Call Transcripts - NASDAQ Seeking View SPHS Breaking News & Analysis - Seeking Alpha
Spotlight View SPHS Annual Report - OTC Report View SPHS OTC Short Report -
TradeKing View SPHS Fundamentals - TradeKing Charts View SPHS SEC Filings - Bar Chart
WSJ View Historical Prices for SPHS - The WSJ Morningstar View Performance/Total Return for SPHS - Morningstar
MarketWatch View the Analyst Estimates for SPHS - MarketWatch CNBC View the Earnings History for SPHS - CNBC
StockMarketWatch View the SPHS Earnings - StockMarketWatch MacroAxis View SPHS Buy or Sell Recommendations - MacroAxis
Bullish View the SPHS Bullish Patterns - American Bulls Short Pains View SPHS Short Pain Metrics -

Social Media Mentions

StockTwits View SPHS Stock Mentions - StockTwits PennyStocks View SPHS Stock Mentions - PennyStockTweets
Twitter View SPHS Stock Mentions - Twitter Invest Hub View SPHS Investment Forum News - Investor Hub
Yahoo View SPHS Stock Mentions - Yahoo! Message Board Seeking Alpha View SPHS Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for SPHS - Insider Cow View Insider Transactions for SPHS - Insider Cow
CNBC View SPHS Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for SPHS - OTC Markets
Yahoo View Insider Transactions for SPHS - Yahoo! Finance NASDAQ View Institutional Holdings for SPHS - NASDAQ

Stock Charts

FinViz View SPHS Stock Insight & Charts - StockCharts View SPHS Investment Charts -
BarChart View SPHS Stock Overview & Charts - BarChart Trading View View SPHS User Generated Charts - Trading View

Latest Financial News for SPHS

SPHS: Interim Data Reported for P2b Study of Topsalysin in Localized Prostate Cancer
Posted on Thursday July 12, 2018

A total of 38 patients received a single administration of topsalysin to treat a clinically significant tumor, which was defined for this study as either a Gleason score of 6 (pattern 3 + 3) and greater than or equal to 6 mm maximum cancer core length (MMCL), or a Gleason score of 7 (pattern 3 + 4) and less than or equal to 10 mm MCCL. Six months following administration of topsalysin each patient received a follow-up biopsy.

Today’s Research Reports on Stocks to Watch: Spectrum Pharmaceuticals and Sophiris
Posted on Wednesday June 27, 2018

NEW YORK, NY / ACCESSWIRE / June 27, 2018 / Spectrum Pharmaceuticals saw its shares rise after a Bloomberg report revealed that the hematology and oncology company may be considering a sale. Shares of Sophiris Bio were bouncing in Tuesday trading after plummeting on Monday when Wall Street learned that a patient had died in the company’s ongoing phase 2b clinical trial for its prostate drug topsalysin. Spectrum Pharmaceuticals, Inc. shares closed up 14.59% on about 6.4 million shares traded yesterday.

Today's Research Reports on Trending Tickers: Sophiris Bio and Achaogen
Posted on Tuesday June 26, 2018

NEW YORK, NY / ACESSWIRE / June 26, 2018 / U.S. equities plunged on Monday, as indexes posted their biggest one-day decline in week, as fresh threats from President Trump added to the uncertainties of ...

Sophiris Bio shares plummet 46% on news of patient death in trial for prostate cancer drug
Posted on Monday June 25, 2018

Sophiris Bio Inc. (sphs) shares plummeted nearly 46% in premarket trade on Monday after the company said that a patient had died in the company's ongoing phase 2b clinical trial for its prostate cancer drug topsalysin. The patient death happened the same day that the patient was administered the drug for the second time, the company said.

Stock Market & Investing Books

Enter a stock symbol to view the stock details.